MedPath

Innovating Post-transplant Care: Employing Donor-Derived Cell-Free DNA measured by SNP for Early Graft Dysfunction Detection"

Not Applicable
Recruiting
Conditions
Heart transplant, Lung Transplant, Liver transplant, Kidney Transplant, Pancreas Transplant
Registration Number
JPRN-UMIN000052656
Lead Sponsor
Keio University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
420
Inclusion Criteria

Not provided

Exclusion Criteria

The provided information outlines certain exclusion criteria for the study: 1. Pregnancy: Pregnant individuals are excluded from participation. 2. Twin-to-Twin Transplants: Cases involving twin-to-twin transplants are not eligible. 3. History of Bone Marrow Transplant: Individuals with a history of bone marrow transplant are not included. 4. Multiple Organ Transplants: The study primarily focuses on single-organ transplant patients. However, exceptions are made for pancreas-kidney simultaneous transplant patients and liver-small intestine simultaneous transplant patients. 5. Re-transplantation: Patients who have undergone re-transplantation are excluded from the study. Note regarding Multiple Organ Transplants: The study allows for exceptions in cases of pancreas-kidney simultaneous transplant patients and liver-small intestine simultaneous transplant patients. These patients may be eligible for registration.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath